Renal cell carcinoma other diagnostic studies: Difference between revisions

	Renal cell carcinoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Renal cell carcinoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural history, Complications and Prognosis
Diagnosis
Staging
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Renal cell carcinoma other diagnostic studies On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Renal cell carcinoma other diagnostic studies All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Renal cell carcinoma other diagnostic studies
CDC on Renal cell carcinoma other diagnostic studies
Renal cell carcinoma other diagnostic studies in the news
Blogs on Renal cell carcinoma other diagnostic studies
Directions to Hospitals Treating Renal cell carcinoma
Risk calculators and risk factors for Renal cell carcinoma other diagnostic studies

Revision as of 16:04, 5 January 2014

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

@@ Line 4: / Line 4: @@
 ==Overview==
-==Other Diagnostic Studies==
+==Histopathology==
-At diagnosis, 30% of renal cell carcinoma has spread to that kidney's renal vein, and 5-10% has continued on into the inferior vena cava<ref>Oto A, Herts BR, Remer EM, Novick AC. Inferior vena cava tumor thrombus in renal cell carcinoma: staging by MR imaging and impact on surgical treatment. AJR Am J Roentgenol. 1998 Dec;171(6):1619-24. PMID 9843299.</ref>.
-Percutaneous biopsy can be performed by a [[radiologist]] using [[medical ultrasonography|ultrasound]] or [[computed tomography]] to guide sampling of the tumor for the purpose of diagnosis.  However this is not routinely performed because when the typical imaging features of renal cell carcinoma are present, the possibility of an incorrectly negative result together with the risk of a medical complication to the patient make it unfavorable from a risk-benefit perspective.This is not completely accurate, there are new experimental treatments.
 ==References==